Literature DB >> 33881756

Screening and Purification of Natural Products from Actinomycetes that Induce a "Rounded" Morphological Phenotype in Fission Yeast.

Richard Alexander Lewis1, Jenileima Devi2, Katherine Green2, Juanjuan Li3, Adam Hopkins2, Jacqueline Hayles4, Paul Nurse4, Jeff Errington2, Nicholas Edward Ellis Allenby2.   

Abstract

This study was designed to identify and investigate bioactive natural product compounds that alter the cellular shape of the fission yeast Schizosaccharomyces pombe and induce a "rounded" or "small" cellular morphological phenotype. Bioassays using a range of antifungal agents against a multidrug-sensitive fission yeast strain, SAK950 showed that many induced a "rounded" phenotype. We then investigated whether 46 of the actinomycete strains identified in our previous study as inducing a similar phenotype produced antifungal agents of similar classes. We show that five of the strains produced streptothricin and that 26 strains produced polyenes, including fungichromin, filipin and candicidin, the last of which was produced by 24 strains. A taxonomic study of the strains indicated that the majority of the candicidin only producers were Streptomyces hydrogenans and S. albidoflavus whilst those that additionally produced streptothricin were related to S. enissocaesilis. A follow-up study to investigate the natural products made by related strains indicated that they followed a similar pattern. The identification of several compounds from the actinomycete strains similar to the antifungal agents initially tested confirm the validity of an approach using the S. pombe morphological phenotype and actinomycete taxonomy as a predictive tool for natural product identification.

Entities:  

Keywords:  Actinomycetes; Antifungal; Morphology; Phenotype; Polyene; Schizosaccharomyces pombe

Year:  2021        PMID: 33881756     DOI: 10.1007/s13659-021-00304-1

Source DB:  PubMed          Journal:  Nat Prod Bioprospect        ISSN: 2192-2209


  64 in total

Review 1.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

2.  Fungicidin, an antibiotic produced by a soil actinomycete.

Authors:  E L HAZEN; R BROWN
Journal:  Proc Soc Exp Biol Med       Date:  1951-01

3.  The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

Authors:  J R Perfect; G M Cox; J Y Lee; C A Kauffman; L de Repentigny; S W Chapman; V A Morrison; P Pappas; J W Hiemenz; D A Stevens
Journal:  Clin Infect Dis       Date:  2001-10-22       Impact factor: 9.079

4.  Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome.

Authors:  J Guinea; M Torres-Narbona; P Gijón; P Muñoz; F Pozo; T Peláez; J de Miguel; E Bouza
Journal:  Clin Microbiol Infect       Date:  2009-11-10       Impact factor: 8.067

Review 5.  Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.

Authors:  Benjamin J Park; Kathleen A Wannemuehler; Barbara J Marston; Nelesh Govender; Peter G Pappas; Tom M Chiller
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

6.  Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome.

Authors:  David T Fisk; Steven Meshnick; Powel H Kazanjian
Journal:  Clin Infect Dis       Date:  2002-12-16       Impact factor: 9.079

7.  Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006.

Authors:  Peter D Walzer; Hannah E R Evans; Andrew J Copas; Simon G Edwards; Alison D Grant; Robert F Miller
Journal:  Clin Infect Dis       Date:  2008-02-15       Impact factor: 9.079

8.  Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area.

Authors:  M Cornet; L Fleury; C Maslo; J-F Bernard; G Brücker
Journal:  J Hosp Infect       Date:  2002-08       Impact factor: 3.926

Review 9.  Hidden killers: human fungal infections.

Authors:  Gordon D Brown; David W Denning; Neil A R Gow; Stuart M Levitz; Mihai G Netea; Theodore C White
Journal:  Sci Transl Med       Date:  2012-12-19       Impact factor: 17.956

10.  Candida glabrata candidemia: An emerging threat in critically ill patients.

Authors:  Ashish Gupta; Anu Gupta; Amit Varma
Journal:  Indian J Crit Care Med       Date:  2015-03
View more
  2 in total

1.  Insights into the Variation in Bioactivities of Closely Related Streptomyces Strains from Marine Sediments of the Visayan Sea against ESKAPE and Ovarian Cancer.

Authors:  Edna M Sabido; Chuckcris P Tenebro; Dana Joanne Von L Trono; Carmela Vannette B Vicera; Sheeny Fane L Leonida; Jose Jeffrey Wayne B Maybay; Rikka Reyes-Salarda; Diana S Amago; Angelica Marie V Aguadera; May C Octaviano; Jonel P Saludes; Doralyn S Dalisay
Journal:  Mar Drugs       Date:  2021-07-31       Impact factor: 5.118

2.  iChip-Inspired Isolation, Bioactivities and Dereplication of Actinomycetota from Portuguese Beach Sediments.

Authors:  José Diogo Neves Dos Santos; Susana Afonso João; Jesús Martín; Francisca Vicente; Fernando Reyes; Olga Maria Lage
Journal:  Microorganisms       Date:  2022-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.